Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT04061824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT04061824
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04061824. Randomized; no masking; primary purpose other. Start 2016-05-24 (actual); primary completion 2018-12-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
- Condition
- Hypertension
- Condition
- Dyslipidemias
- Intervention (Drug)
- Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
- Intervention (Drug)
- Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct04061824- Content hash
f929eb61f89f58ea91359c6d3b93b9c6586b5d1c7b44b29e471c57e74e94caa4